Insulin Analog [EPC]

360683 reported adverse events

Drugs of this class: INSULIN GLARGINE INSULIN ASPART INSULIN LISPRO INSULIN DEGLUDEC INSULIN DETEMIR INSULIN GLARGINE-YFGN (INSULIN DEGLUDEC AND LIRAGLUTIDE) ATTENTION DEFICIT MILD DROPS ATTENTION DEFICIT SEVERE DROPS DNA INSULIN DROPS INSULIN

These side effects are most commonly reported by patients taking drugs of the Insulin Analog [EPC] class:

#	Side effect	Count
0	BLOOD GLUCOSE INCREASED	68344
1	DRUG INEFFECTIVE	18290
2	BLOOD GLUCOSE DECREASED	17349
3	NAUSEA	15715
4	HYPOGLYCAEMIA	12036
5	FATIGUE	11270
6	DIARRHOEA	10992
7	VISUAL IMPAIRMENT	10971
8	DYSPNOEA	10940
9	MALAISE	10934

See all common reactions for Insulin Analog [EPC]

Drugs of the Insulin Analog [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	DEVICE OPERATIONAL ISSUE	1995	0.7977
1	HYPOGLYCAEMIA UNAWARENESS	233	0.7082
2	HYPOGLYCAEMIC UNCONSCIOUSNESS	1184	0.6644
3	HYPOGLYCAEMIC SEIZURE	419	0.5251
4	DIABETIC RETINOPATHY	1399	0.5140
5	SHOCK HYPOGLYCAEMIC	209	0.5036
6	INTERCEPTED PRODUCT SELECTION ERROR	275	0.4669
7	BLOOD GLUCOSE FLUCTUATION	4168	0.4569
8	INSULIN RESISTANCE	695	0.4458
9	BLOOD GLUCOSE INCREASED	68344	0.4362

See all enriched reactions for Insulin Analog [EPC]